Ertapenem sodium infusion (Invanz) Paediatric for intra-abdominal infections in children and adolescents - Abbreviated submission

Reference: Date Advice Issued: 7 August 2006

Source: Scottish Medicines Consortium (SMC)

Date published: 08/05/2007 00:00

Summary
by: Anonymous

Ertapenem sodium infusion (Invanz) Paediatric

Ertapenem sodium infusion (Invanz®) (291/06) - Merck Sharp & Dohme 07 August 2006

The Scottish Medicines Consortium (SMC) issues advice on ertapenem sodium infusion (Invanz®), for use within NHSScotland.

SMC advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) that ertapenem sodium infusion (Invanz) Paediatric is accepted for restricted use within NHS Scotland for the treatment of intra-abdominal infections in children and adolescents. Ertapenem should only be used second-line for the treatment of the community acquired intra-abdominal infections resistant to the current conventional treatments and under the advice of local microbiologists or specialists in infectious diseases.

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Related evidence
5.1.2 Cephalosporins, carbapenems, and other beta-lactams
Adolescents (11-18 years)
Bacterial
Children (2-11 years)
Infection